Latest Customer Growth News

Medibank has set ambitious goals to triple its health segment earnings by FY30, expand its private health insurance market share, and double its health engagement, signaling a strategic pivot towards integrated, technology-driven care.

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

ikeGPS has reported a robust first half of FY26 with subscription revenue soaring 47%, a successful A$24 million capital raise, and inclusion in the ASX All Ordinaries Index, underscoring its expanding footprint in the US grid modernization market.

Raiz Invest has hit a record $2 billion in funds under management, driven by strong customer growth and innovative product launches. The fintech’s latest quarter also saw strategic partnerships expand its market reach.

Bank of Queensland reports a 12% rise in cash earnings for FY25 despite a 53% drop in statutory profit due to one-off impairments and restructuring. The bank’s strategic pivot towards commercial lending and digital transformation underpins improved operational performance and shareholder returns.

Meridian Energy’s September 2025 report reveals exceptional hydro storage levels and a notable uptick in electricity demand and retail sales, setting a positive tone for the company’s near-term outlook.

Raiz Invest Limited reported robust FY25 results with record active customers and funds under management, underpinned by strategic partnerships and AI-driven innovation. The company projects positive earnings growth for FY26 amid a competitive fintech landscape.

McMillan Shakespeare Limited reported steady FY25 growth with Normalised UNPATA of $103.2 million and an 8.3% dividend yield, underpinned by digital innovation and strategic investments.

McMillan Shakespeare Limited reported a 14.1% rise in statutory net profit for FY25, marking the completion of its transformative Simply Stronger program that enhanced digital offerings and customer reach.

Control Bionics Limited has announced a $2.06 million non-renounceable rights issue to fund the commercial expansion of its NeuroStrip device and bolster NeuroNode operations. The capital raise is underwritten to approximately $1.15 million by major shareholders and strategic partners.

XPON Technologies Group Ltd reported a strategic acquisition and a near elimination of EBITDA losses in FY25, signaling a pivot towards sustainable growth in AI marketing technology.

Medibank has reported strong full-year results for 2025, with underlying net profit rising 8.5% and record policyholder growth, underpinned by disciplined cost management and strategic health investments.